Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...

Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.

Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical ...

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

Saint Alphonsus in Boise earned a three-star TAVR ranking from STS and ACC, placing it among the nation’s top heart programs ...

Please provide your email address to receive an email when new articles are posted on . In patients with small aortic annuli requiring TAVR, self-expanding valves had better hemodynamic results than ...

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is conducting ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

Please provide your email address to receive an email when new articles are posted on . Raj R. Makkar, MD, vice president of cardiovascular innovation and intervention and the Stephen R. Corday, MD, ...

Repeat transcatheter aortic valve replacement (TAVR), that is, TAVR performed within a failed TAVR valve, is associated with about half the short-term mortality of an alternative procedure, TAVR-valve ...

The Global Transcatheter Aortic Valve Replacement (TAVR) Market is set to play a transformative role in cardiovascular care, enabling patients with severe aortic stenosis to receive life-saving ...